AMNEAL PHARMACEUTICALS, INC. (AMRX) vs Lantheus Holdings, Inc. (LNTH)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.18 −0.36%
- Lantheus Holdings, Inc. LNTH 99.70 −0.29%
AMNEAL PHARMACEUTICALS, INC. and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. and Lantheus Holdings, Inc. are of similar size ($6.5B and $6.2B). Lantheus Holdings, Inc. trades at the lower P/E: 23.7× against 38.4×. AMNEAL PHARMACEUTICALS, INC. grew revenue faster over the last twelve months: 9.28% against 2.35%. Lantheus Holdings, Inc. has the higher net margin (17.7% vs 5.05%) and the higher return on invested capital (14.7% vs 11.1%). Across the 21 metrics below, Lantheus Holdings, Inc. leads on 16 and AMNEAL PHARMACEUTICALS, INC. on 5.
Valuation
Profitability
| Metric | AMRX | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 39.32% | 60.14% | 53.94% |
| Operating margin | 14.56% | 19.43% | 0.00% |
| Net margin | 5.05% | 17.69% | 0.00% |
| Free cash flow margin | (0.37%) | 25.24% | 0.00% |
| Return on equity | (395.84%) | 22.21% | (0.40%) |
| Return on assets | 4.37% | 12.15% | (3.32%) |
| Return on invested capital | 11.05% | 14.65% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack